Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AntaMIn - Intranasal Fentanyl or Ketamine vs Oral Morphine for Pediatric Limb Injury Pain
2023-506803-25-01Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Intranasal fentanyl, Intranasal ketamine and Oral morphine (3 arms). Primary endpoint: Primary analgesic success at 30 minutes. Planned start May 2024; status: authorised.
02
Drugs
fentanylketaminemorphine
Beyond the preview
Go deeper on 2023-506803-25-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506803-25-01.